Nuclear imaging for cardiac amyloidosis
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605479186 | ||
| 003 | CHVBK | ||
| 005 | 20210128100409.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20150301xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10741-014-9463-6 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10741-014-9463-6 | ||
| 245 | 0 | 0 | |a Nuclear imaging for cardiac amyloidosis |h [Elektronische Daten] |c [Walter Noordzij, Andor Glaudemans, Simone Longhi, Riemer Slart, Massimiliano Lorenzini, Bouke Hazenberg, Claudio Rapezzi] |
| 520 | 3 | |a Histological analysis of endomyocardial tissue is still the gold standard for the diagnosis of cardiac amyloidosis, but has its limitations. Accordingly, there is a need for non-invasive modalities to diagnose cardiac amyloidosis. Echocardiography and ultrasound and magnetic resonance imaging can show characteristics which may not be very specific for cardiac amyloid. Nuclear medicine has gained a precise role in this context: several imaging modalities have become available for the diagnosis and prognostic stratification of cardiac amyloidosis during the last two decades. The different classes of radiopharmaceuticals have the potential to bind different constituents of the amyloidotic infiltrates, with some relevant differences among the various aetiologic types of amyloidosis and the different organs and tissues involved. This review focuses on the background of the commonly used modalities, their present clinical applications, and future clinical perspectives in imaging patients with (suspected) cardiac amyloidosis. The main focus is on conventional nuclear medicine (bone scintigraphy, cardiac sympathetic innervation) and positron emission tomography. | |
| 540 | |a Springer Science+Business Media New York, 2014 | ||
| 690 | 7 | |a Amyloidosis |2 nationallicence | |
| 690 | 7 | |a Nuclear medicine |2 nationallicence | |
| 690 | 7 | |a PET |2 nationallicence | |
| 690 | 7 | |a MIBG |2 nationallicence | |
| 690 | 7 | |a Bone scintigraphy |2 nationallicence | |
| 700 | 1 | |a Noordzij |D Walter |u Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands |4 aut | |
| 700 | 1 | |a Glaudemans |D Andor |u Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands |4 aut | |
| 700 | 1 | |a Longhi |D Simone |u Department of Cardiology, University of Bologna, Bologna, Italy |4 aut | |
| 700 | 1 | |a Slart |D Riemer |u Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands |4 aut | |
| 700 | 1 | |a Lorenzini |D Massimiliano |u Department of Cardiology, University of Bologna, Bologna, Italy |4 aut | |
| 700 | 1 | |a Hazenberg |D Bouke |u Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands |4 aut | |
| 700 | 1 | |a Rapezzi |D Claudio |u Department of Cardiology, University of Bologna, Bologna, Italy |4 aut | |
| 773 | 0 | |t Heart Failure Reviews |d Springer US; http://www.springer-ny.com |g 20/2(2015-03-01), 145-154 |x 1382-4147 |q 20:2<145 |1 2015 |2 20 |o 10741 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10741-014-9463-6 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10741-014-9463-6 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Noordzij |D Walter |u Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Glaudemans |D Andor |u Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Longhi |D Simone |u Department of Cardiology, University of Bologna, Bologna, Italy |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Slart |D Riemer |u Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Lorenzini |D Massimiliano |u Department of Cardiology, University of Bologna, Bologna, Italy |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Hazenberg |D Bouke |u Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Rapezzi |D Claudio |u Department of Cardiology, University of Bologna, Bologna, Italy |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Heart Failure Reviews |d Springer US; http://www.springer-ny.com |g 20/2(2015-03-01), 145-154 |x 1382-4147 |q 20:2<145 |1 2015 |2 20 |o 10741 | ||